Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 2
2001 2
2002 2
2004 2
2008 1
2009 2
2012 2
2016 1
2018 1
2019 1
2020 4
2021 5
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Wilt TJ, et al. JAMA. 1998 Nov 11;280(18):1604-9. doi: 10.1001/jama.280.18.1604. JAMA. 1998. PMID: 9820264
OBJECTIVE: To conduct a systematic review and, where possible, quantitative meta-analysis of the existing evidence regarding the therapeutic efficacy and safety of the saw palmetto plant extract, Serenoa repens, in men with symptomatic benign …
OBJECTIVE: To conduct a systematic review and, where possible, quantitative meta-analysis of the existing evidence regarding t …
Phytotherapy for benign prostatic hyperplasia.
Wilt TJ, Ishani A, Rutks I, MacDonald R. Wilt TJ, et al. Public Health Nutr. 2000 Dec;3(4A):459-72. doi: 10.1017/s1368980000000549. Public Health Nutr. 2000. PMID: 11276294
The studies were included if men had symptomatic benign prostatic hyperplasia, the intervention was a phytotherapeutic preparation alone or combined, a control group received placebo or other pharmacologic therapies for BPH, and the treatment duration was at …
The studies were included if men had symptomatic benign prostatic hyperplasia, the intervention was a phytotherapeutic …
Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
Cai T, Cui Y, Yu S, Li Q, Zhou Z, Gao Z. Cai T, et al. Am J Mens Health. 2020 Mar-Apr;14(2):1557988320905407. doi: 10.1177/1557988320905407. Am J Mens Health. 2020. PMID: 32274957 Free PMC article.
Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic …
Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a syste …
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon( ) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.
Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, Castro Díaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero García JM, Fernández-Pro Ledesma A, Cózar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V. Vela-Navarrete R, et al. BJU Int. 2018 Dec;122(6):1049-1065. doi: 10.1111/bju.14362. Epub 2018 Jun 6. BJU Int. 2018. PMID: 29694707 Free article.
OBJECTIVES: To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, Permixon( ) ; Pierre Fabre Medicament, Castres, France), at a dose of 320 mg daily, as monotherapy for the treatment of lower urinary tract symptoms associated w …
OBJECTIVES: To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, Permixon( ) ; Pierre …
Serenoa repens for benign prostatic hyperplasia.
Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Tacklind J, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2023 Jun 22;6:CD001423. doi: 10.1002/14651858.CD001423.pub4. PMID: 23235581 Free PMC article. Updated.
BACKGROUND: Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate, which can lead to obstructive and irritative lower urinary tract symptoms (LUTS). ...The extract of the berry of the American saw palmetto, or dwarf pa …
BACKGROUND: Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate, which can lead to obstruc …
Serenoa repens for benign prostatic hyperplasia.
Tacklind J, MacDonald R, Rutks I, Wilt TJ. Tacklind J, et al. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. PMID: 19370565 Free PMC article. Updated.
BACKGROUND: Benign prostatic hyperplasia (BPH), a nonmalignant enlargement of the prostate, can lead to obstructive and irritative lower urinary tract symptoms (LUTS). ...The extract of the berry of the American saw palmetto, or dwarf palm plant …
BACKGROUND: Benign prostatic hyperplasia (BPH), a nonmalignant enlargement of the prostate, can lead to obstructive and …
Plant extracts: sense or nonsense?
Madersbacher S, Berger I, Ponholzer A, Marszalek M. Madersbacher S, et al. Curr Opin Urol. 2008 Jan;18(1):16-20. doi: 10.1097/MOU.0b013e3282f0d5c8. Curr Opin Urol. 2008. PMID: 18090484 Review.
One trial compared a saw palmetto extract with placebo. This industry-independent trial published in the New England Journal of Medicine was negative, that is, this saw palmetto extract had no effect on symptoms, Qmax and postvoid residua …
One trial compared a saw palmetto extract with placebo. This industry-independent trial published in the New England Jo …
Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI, Scandura C, Di Mauro M, Cacciamani G, Albersen M, Hatzichristodoulou G, Fode M, Capogrosso P, Cimino S, Marcelissen T, Cornu JN, Gacci M, Minervini A, Cocci A; European Association of Urology Young Academic Urologists (EAU-YAU) Men’s Health and Functional Urology Working Groups. Russo GI, et al. Eur Urol Focus. 2021 Mar;7(2):420-431. doi: 10.1016/j.euf.2020.01.002. Epub 2020 Jan 15. Eur Urol Focus. 2021. PMID: 31952967
CONTEXT: International guidelines do not make any specific recommendations on Serenoa repens (SeR) for the treatment of male lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement (BPE), due to product heterogeneity and methodological l …
CONTEXT: International guidelines do not make any specific recommendations on Serenoa repens (SeR) for the treatment of male lower ur …
Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Novara G, Giannarini G, Alcaraz A, Cózar-Olmo JM, Descazeaud A, Montorsi F, Ficarra V. Novara G, et al. Eur Urol Focus. 2016 Dec;2(5):553-561. doi: 10.1016/j.euf.2016.04.002. Epub 2016 Apr 23. Eur Urol Focus. 2016. PMID: 28723522 Review.
CONTEXT: A recent Cochrane Collaboration meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy of different extracts of Serenoa repens in relieving lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia …
CONTEXT: A recent Cochrane Collaboration meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy of diffe …
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis.
Trivisonno LF, Sgarbossa N, Alvez GA, Fieiras C, Escobar Liquitay CM, Jung JH, Franco JVA. Trivisonno LF, et al. Investig Clin Urol. 2021 Sep;62(5):520-534. doi: 10.4111/icu.20210254. Investig Clin Urol. 2021. PMID: 34488251 Free PMC article.
PURPOSE: To assess the effects of Serenoa repens alone or in combination with other phytotherapy compared to placebo in men with LUTS due to benign prostatic enlargement. ...We included randomized controlled trials, and we critically appraised them using the …
PURPOSE: To assess the effects of Serenoa repens alone or in combination with other phytotherapy compared to placebo in men with LUTS …
26 results